167 related articles for article (PubMed ID: 12076502)
21. Penicillamine for treating rheumatoid arthritis.
Suarez-Almazor ME; Spooner C; Belseck E
Cochrane Database Syst Rev; 2000; (4):CD001460. PubMed ID: 11034719
[TBL] [Abstract][Full Text] [Related]
22. Adalimumab for treating rheumatoid arthritis.
Navarro-Sarabia F; Ariza-Ariza R; Hernandez-Cruz B; Villanueva I
Cochrane Database Syst Rev; 2005 Jul; (3):CD005113. PubMed ID: 16034967
[TBL] [Abstract][Full Text] [Related]
23. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
[TBL] [Abstract][Full Text] [Related]
24. Effects of rofecoxib and naproxen on life expectancy among patients with rheumatoid arthritis: a decision analysis.
Choi HK; Seeger JD; Kuntz KM
Am J Med; 2004 May; 116(9):621-9. PubMed ID: 15093759
[TBL] [Abstract][Full Text] [Related]
25. Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program.
Weir MR; Sperling RS; Reicin A; Gertz BJ
Am Heart J; 2003 Oct; 146(4):591-604. PubMed ID: 14564311
[TBL] [Abstract][Full Text] [Related]
26. Analgesic efficacy of the cyclooxygenase-inhibiting nitric oxide donor AZD3582 in postoperative dental pain: Comparison with naproxen and rofecoxib in two randomized, double-blind, placebo-controlled studies.
Michael Hill C; Sindet-Pederson S; Seymour RA; Hawkesford JE; Coulthard P; Lamey PJ; Gerry Cowan C; Wickens M; Jeppsson L; Dean AD; Svensson O
Clin Ther; 2006 Sep; 28(9):1279-95. PubMed ID: 17062301
[TBL] [Abstract][Full Text] [Related]
27. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.
Laine L; Connors LG; Reicin A; Hawkey CJ; Burgos-Vargas R; Schnitzer TJ; Yu Q; Bombardier C
Gastroenterology; 2003 Feb; 124(2):288-92. PubMed ID: 12557133
[TBL] [Abstract][Full Text] [Related]
28. An observational, retrospective, cohort study of dosing patterns for rofecoxib and celecoxib in the treatment of arthritis.
Schnitzer TJ; Kong SX; Mitchell JH; Mavros P; Watson DJ; Pellissier JM; Straus WL
Clin Ther; 2003 Dec; 25(12):3162-72. PubMed ID: 14749154
[TBL] [Abstract][Full Text] [Related]
29. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S;
J Rheumatol; 2002 Aug; 29(8):1623-30. PubMed ID: 12180720
[TBL] [Abstract][Full Text] [Related]
30. Single dose oral naproxen and naproxen sodium for acute postoperative pain.
Mason L; Edwards JE; Moore RA; McQuay HJ
Cochrane Database Syst Rev; 2004 Oct; (4):CD004234. PubMed ID: 15495091
[TBL] [Abstract][Full Text] [Related]
31. A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.
Geusens PP; Truitt K; Sfikakis P; Zhao PL; DeTora L; Shingo S; Lau CS; Kalla A; Tate G
Scand J Rheumatol; 2002; 31(4):230-8. PubMed ID: 12369656
[TBL] [Abstract][Full Text] [Related]
32. Cyclophosphamide for treating rheumatoid arthritis.
Suarez-Almazor ME; Belseck E; Shea B; Wells G; Tugwell P
Cochrane Database Syst Rev; 2000; (4):CD001157. PubMed ID: 11034702
[TBL] [Abstract][Full Text] [Related]
33. Rofecoxib: clinical pharmacology and clinical experience.
Weaver AL
Clin Ther; 2001 Sep; 23(9):1323-38. PubMed ID: 11589252
[TBL] [Abstract][Full Text] [Related]
34. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis.
Laine L; Bombardier C; Hawkey CJ; Davis B; Shapiro D; Brett C; Reicin A
Gastroenterology; 2002 Oct; 123(4):1006-12. PubMed ID: 12360461
[TBL] [Abstract][Full Text] [Related]
35. Methotrexate for ankylosing spondylitis.
Chen J; Liu C
Cochrane Database Syst Rev; 2004; (3):CD004524. PubMed ID: 15266537
[TBL] [Abstract][Full Text] [Related]
36. Rofecoxib in rheumatoid arthritis: new indication. No better that other NSAIDS.
Prescrire Int; 2003 Jun; 12(65):89-90. PubMed ID: 12825570
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee.
Schnitzer TJ; Kivitz AJ; Lipetz RS; Sanders N; Hee A
Arthritis Rheum; 2005 Dec; 53(6):827-37. PubMed ID: 16342089
[TBL] [Abstract][Full Text] [Related]
38. New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
Hochberg MC
Semin Arthritis Rheum; 2002 Dec; 32(3 Suppl 1):4-14. PubMed ID: 12528069
[TBL] [Abstract][Full Text] [Related]
39. The Effects of cyclooxygenase-2 inhibitors and nonsteroidal anti-inflammatory therapy on 24-hour blood pressure in patients with hypertension, osteoarthritis, and type 2 diabetes mellitus.
Sowers JR; White WB; Pitt B; Whelton A; Simon LS; Winer N; Kivitz A; van Ingen H; Brabant T; Fort JG;
Arch Intern Med; 2005 Jan; 165(2):161-8. PubMed ID: 15668361
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis.
Feng X; Tian M; Zhang W; Mei H
PLoS One; 2018; 13(1):e0190798. PubMed ID: 29320568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
